{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T08:48:32Z","timestamp":1753519712358},"reference-count":47,"publisher":"American Chemical Society (ACS)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chem. Res. Toxicol."],"published-print":{"date-parts":[[2004,9,1]]},"DOI":"10.1021\/tx049899e","type":"journal-article","created":{"date-parts":[[2004,9,20]],"date-time":"2004-09-20T04:21:17Z","timestamp":1095654077000},"page":"1177-1189","source":"Crossref","is-referenced-by-count":15,"title":["Role of Cytochrome P4503A in Cysteine S-Conjugates Sulfoxidat\u0131on and the Nephrotoxicity of the Sevoflurane Degradat\u0131on Product Fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl Ether (Compound A) in Rats"],"prefix":"10.1021","volume":"17","author":[{"given":"Pam","family":"Sheffels","sequence":"first","affiliation":[{"name":"Departments of Anesthesiology, Comparative Medicine, and Medicinal Chemistry, University of Washington, Seattle, Washington 98195-6540, and Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ankara University, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesara L.","family":"Schroeder","sequence":"additional","affiliation":[{"name":"Departments of Anesthesiology, Comparative Medicine, and Medicinal Chemistry, University of Washington, Seattle, Washington 98195-6540, and Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ankara University, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Gul","family":"Altuntas","sequence":"additional","affiliation":[{"name":"Departments of Anesthesiology, Comparative Medicine, and Medicinal Chemistry, University of Washington, Seattle, Washington 98195-6540, and Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ankara University, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Denny","family":"Liggitt","sequence":"additional","affiliation":[{"name":"Departments of Anesthesiology, Comparative Medicine, and Medicinal Chemistry, University of Washington, Seattle, Washington 98195-6540, and Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ankara University, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan D.","family":"Kharasch","sequence":"additional","affiliation":[{"name":"Departments of Anesthesiology, Comparative Medicine, and Medicinal Chemistry, University of Washington, Seattle, Washington 98195-6540, and Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ankara University, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[2004,8,18]]},"reference":[{"key":"tx049899eb00001\/tx049899eb00001_1","first-page":"67","volume":"36","author":"Hanaki C.","year":"1987","journal-title":"Hiroshima J. Med. Sci."},{"key":"tx049899eb00002\/tx049899eb00002_1","volume-title":"Quantification of the degradation products of sevoflurane in two CO2 absorbents during low-flow anesthesia in surgical patients. Anesthesiology 77, 1064\u22121069","author":"Frink E. J., Jr.","year":"1992"},{"key":"tx049899eb00003\/tx049899eb00003_1","volume-title":"Reaction of sevoflurane and its degradation products with soda lime. Toxicity of the byproducts. Anesthesiology 77, 1155\u22121164","author":"Morio M.","year":"1992"},{"key":"tx049899eb00004\/tx049899eb00004_1","volume-title":"Toxicity of compound A in rats. Effect of increasing duration of administration. Anesthesiology 80, 566\u2212573","author":"Gonsowski C. T.","year":"1994"},{"key":"tx049899eb00005\/tx049899eb00005_1","volume-title":"Toxicity of compound A in rats. Effect of a 3-hour administration. Anesthesiology 80, 556\u2212565","author":"Gonsowski C. T.","year":"1994"},{"key":"tx049899eb00006\/tx049899eb00006_1","volume-title":"Compound A (PIFE), in Sprague\u2212Dawley rats. Anesthesiology 83, 1220\u22121232.","author":"Keller K. A.","year":"1995"},{"key":"tx049899eb00007\/tx049899eb00007_1","volume-title":"Role of renal cysteine conjugate b-lyase in the mechanism of compound A nephrotoxicity in rats. Anesthesiology 86, 160\u2212171","author":"Kharasch E. D.","year":"1997"},{"key":"tx049899eb00008\/tx049899eb00008_1","volume-title":"Role of the renal cysteine conjugate b-lyase pathway in inhaled compound A nephrotoxicity in rats. Anesthesiology 88, 1624\u22121633","author":"Kharasch E. D.","year":"1998"},{"key":"tx049899eb00009\/tx049899eb00009_1","volume-title":"Bioactivation of tetrachloroethylene. Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation. Drug Metab. Dispos. 15, 702\u2212709","author":"Dekant W.","year":"1987"},{"key":"tx049899eb00010\/tx049899eb00010_1","doi-asserted-by":"crossref","DOI":"10.1021\/ja00013a090","volume":"113","author":"Dekant W.","year":"1991","journal-title":"J. Am. Chem. Soc."},{"key":"tx049899eb00011\/tx049899eb00011_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/toxsci\/48.1.5","volume":"48","author":"P\u00e4hler A.","year":"1999","journal-title":"Toxicol. Sci."},{"key":"tx049899eb00012\/tx049899eb00012_1","doi-asserted-by":"crossref","unstructured":"Jin, L., Baillie, T. A., Davis, M. R., and Kharasch, E. D. (1995) Nephrotoxicity of sevoflurane compound A [fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether) in rats:\u2009 Evidence for glutathione and cysteine conjugate formation and the role of renal cysteine conjugate b-lyase.Biochem. Biophys. Res Commun.210, 498\u2212506.","DOI":"10.1006\/bbrc.1995.1688"},{"key":"tx049899eb00013\/tx049899eb00013_1","doi-asserted-by":"crossref","unstructured":"Jin, L., Davis, M. R., Kharasch, E. D., Doss, G. A., and Baillie, T. A. (1996) Identification in rat bile of glutathione conjugates of fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether, a nephrotoxic degradate of the anesthetic agent sevoflurane.Chem. Res. Toxicol.9, 555\u2212561.","DOI":"10.1021\/tx950162m"},{"key":"tx049899eb00014\/tx049899eb00014_1","volume-title":"Evidence for the metabolism of fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A), by cysteine conjugate \u03b2-lyase in rats. Chem. Res. Toxicol. 9, 696\u2212702","author":"Spracklin D.","year":"1996"},{"key":"tx049899eb00015\/tx049899eb00015_1","doi-asserted-by":"crossref","unstructured":"Iyer, R. A., Frink, E. J., Jr., Ebert, T. J., and Anders, M. W. (1998) Cysteine conjugate \u03b2-lyase-dependent metabolism of compound A (2-[fluoromethoxy]-1,1,3,3,3-pentafluoro-1-propene) in human subjects anesthetized with sevoflurane and in rats given compound A.Anesthesiology88, 611\u2212618.","DOI":"10.1097\/00000542-199803000-00009"},{"key":"tx049899eb00016\/tx049899eb00016_1","doi-asserted-by":"crossref","unstructured":"Iyer, R. A., and Anders, M. W. (1997) Cysteine conjugate \u03b2-lyase-dependent biotransformation of the cysteineS-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A).Chem. Res. Toxicol.10, 811\u2212819.","DOI":"10.1021\/tx960196+"},{"key":"tx049899eb00017\/tx049899eb00017_1","doi-asserted-by":"crossref","unstructured":"Iyer, R. A., and Anders, M. W. (1996) Cysteine conjugate \u03b2-lyase-dependent biotransformation of the cysteineS-conjugates of the sevoflurane degradation product compound A in human, nonhuman primate, and rat kidney cytosol and mitochondria.Anesthesiology85, 1454\u22121461.","DOI":"10.1097\/00000542-199612000-00028"},{"key":"tx049899eb00018\/tx049899eb00018_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/taap.1999.8751","volume":"160","author":"Kharasch E. D.","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"tx049899eb00019\/tx049899eb00019_1","doi-asserted-by":"crossref","unstructured":"Tong, Z., and Anders, M. W. (2002) Reactive intermediate formation from the 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A)-derived cysteine S-conjugate S-[2-(fluoromethoxy)-1,1,3,3,3-pentafluoropropyl]-l-cysteine in pyridoxal model systems.Chem. Res. Toxicol.15, 623\u2212628.","DOI":"10.1021\/tx010148b"},{"key":"tx049899eb00020\/tx049899eb00020_1","volume":"283","author":"Iyer R. A.","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"tx049899eb00021\/tx049899eb00021_1","volume-title":"Flavin-containing monooxygenase-dependent stereoselective S-oxygenation and cytotoxicity of cysteine S-conjugates and mercapturates. Chem. Res. Toxicol. 5, 193\u2212201","author":"Park S. B.","year":"1992"},{"key":"tx049899eb00022\/tx049899eb00022_1","volume":"269","author":"Lash L. H.","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"tx049899eb00023\/tx049899eb00023_1","volume-title":"The sulfoxidation of the hexachlorobutadiene metabolite N-acetyl-S-(1,2,3,4,4-pentachlorobutadienyl)-l-cysteine is catalyzed by human cytochrome P450 3A enzymes. Chem. Res. Toxicol. 8, 917\u2212923","author":"Werner M.","year":"1995"},{"key":"tx049899eb00024\/tx049899eb00024_1","volume-title":"N-acetyl-S-(pentachlorobutadienyl)-l-cysteine in rats. Drug Metab. Dispos. 23, 861\u2212868.","author":"Werner M.","year":"1995"},{"key":"tx049899eb00025\/tx049899eb00025_1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1021\/tx950075u","volume":"9","author":"Werner M.","year":"1996","journal-title":"Chem. Res. Toxicol."},{"key":"tx049899eb00026\/tx049899eb00026_1","volume-title":"Biotransformation, excretion, and nephrotoxicity of the hexachlorobutadiene metabolite (E)-N-acetyl-S-(1,2,3,4,4-pentachlorobutadienyl)-l-cysteine sulfoxide. Chem. Res. Toxicol. 11, 750\u2212757","author":"Birner G.","year":"1998"},{"key":"tx049899eb00027\/tx049899eb00027_1","volume-title":"Sulfoxidation of cysteine and mercapturic acid conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compund A). Chem. Res. Toxicol. 17, 435\u2212445","author":"Altuntas T. G.","year":"2004"},{"key":"tx049899eb00028\/tx049899eb00028_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0041-008X(03)00336-3","volume":"193","author":"Altuntas T. G.","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"tx049899eb00029\/tx049899eb00029_1","unstructured":"Ko, K.Y., and Kim, J.Y. (1999) Generation of diphenyldiazomethane by oxidation of benzophenone hydrazone with Magtrieve.Bull. Korean Chem. Soc.20, 771\u2212772."},{"key":"tx049899eb00030\/tx049899eb00030_1","volume-title":"Regulation of rat multidrug resistance protein 2 by classes of prototypical microsomal enzyme inducers that activate distinct transcription pathways. Toxicol. Sci. 67, 182\u2212189","author":"Johnson D. R.","year":"2002"},{"key":"tx049899eb00031\/tx049899eb00031_1","first-page":"62","volume":"27","author":"Kostrubsky V.","year":"1997","journal-title":"Ann. Clin. Lab. Sci."},{"key":"tx049899eb00032\/tx049899eb00032_1","volume":"288","author":"Yu L. J.","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"tx049899eb00033\/tx049899eb00033_1","volume-title":"Sex differences in hexachlorobutadiene biotransformation and nephrotoxicity. Toxicol. Appl. Pharmacol. 132, 203\u2212212","author":"Birner G.","year":"1995"},{"key":"tx049899eb00034\/tx049899eb00034_1","volume-title":"S-(1,2,2-trichlorovinyl)-l-cysteine, S-allyl-l-cysteine, and S-benzyl-l-cysteine. Mol. Pharmacol. 51, 507\u2212515.","author":"Ripp S. L.","year":"1997"},{"key":"tx049899eb00035\/tx049899eb00035_1","doi-asserted-by":"crossref","unstructured":"Sausen, P. J., and Elfarra, A. A. (1991) Reactivity of cysteineS-conjugate sulfoxides:\u2009 Formation ofS-[1-chloro-2-(S-glutathionyl)vinyl]-l-cysteine sulfoxide by the reaction ofS-(1,2-dichlorovinyl)-l-cysteine sulfoxide with glutathione.Chem. Res. Toxicol.4, 655\u2212660.","DOI":"10.1021\/tx00024a010"},{"key":"tx049899eb00036\/tx049899eb00036_1","volume":"305","author":"Lash L. H.","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"tx049899eb00037\/tx049899eb00037_1","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.102.042911","volume":"304","author":"Krause R. J.","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"tx049899eb00038\/tx049899eb00038_1","volume-title":"Formation of an inactive cytochrome P-450 Fe(II)-metabolite complex after administration of troleandomycin in humans. Biochem. Pharmacol. 31, 1699\u22121704","author":"Pessayre D.","year":"1982"},{"key":"tx049899eb00039\/tx049899eb00039_1","volume-title":"Stereoselective formation of glutathione S-conjugates from halovinylmercapturate sulphoxides. Xenobiotica 29, 327\u2212340","author":"Rosner E.","year":"1999"},{"key":"tx049899eb00040\/tx049899eb00040_1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1021\/tx970127a","volume":"11","author":"Rosner E.","year":"1998","journal-title":"Chem. Res. Toxicol."},{"key":"tx049899eb00041\/tx049899eb00041_1","volume-title":"Formation and fate of nephrotoxic and cytotoxic glutathione-S-conjugates:\u2009 Cysteine conjugate \u03b2-lyase pathway. Adv. Pharmacol. 27, 115\u2212162","author":"Dekant W.","year":"1994"},{"key":"tx049899eb00042\/tx049899eb00042_1","volume-title":"Mercapturic acids (N-acetylcysteine S-conjugates) as endogenous substrates for the renal organic anion transporter-1. Mol. Pharmacol. 60, 1091\u22121099","author":"Pombrio J. M.","year":"2001"},{"key":"tx049899eb00043\/tx049899eb00043_1","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.102.043455","volume":"304","author":"Groves C. E.","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"tx049899eb00044\/tx049899eb00044_1","doi-asserted-by":"crossref","unstructured":"Bahn, A., Hauss, A., Appenroth, D., Ebbinghaus, D., Hagos, Y., Steinmetzer, P., Burckhardt, G., and Fleck, C. (2003) RT-PCR-based evidence for the in vivo stimulation of renal tubularp-aminohippurate (PAH) transport by triiodothyronine (T3) or dexamethasone (DEXA) in kidney tissue of immature and adult rats.Exp. Toxicol. Pathol.54, 367\u2212373.","DOI":"10.1078\/0940-2993-00272"},{"key":"tx049899eb00045\/tx049899eb00045_1","volume":"300","author":"Guo G. L.","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"tx049899eb00046\/tx049899eb00046_1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1124\/jpet.300.1.97","volume":"300","author":"Cherrington N. J.","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"tx049899en00001\/tx049899en00001_1","volume-title":"fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether","author":"Abbreviations FDVE"}],"container-title":["Chemical Research in Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/tx049899e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T10:40:41Z","timestamp":1633344041000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/tx049899e"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,18]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9,1]]}},"alternative-id":["10.1021\/tx049899e"],"URL":"https:\/\/doi.org\/10.1021\/tx049899e","relation":{},"ISSN":["0893-228X","1520-5010"],"issn-type":[{"value":"0893-228X","type":"print"},{"value":"1520-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,18]]}}}